Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.
Stürzebecher
S
S
Research Laboratories of Schering AG Berlin West, FRG.
Nieuweboer
B
B
Matthes
S
S
Schillinger
E
E
D000527:Alprostadil / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology; D002469:Cell Separation; D011464:Epoprostenol / Q000494:pharmacology / Q000031:analogs & derivatives; D006801:Humans; D016285:Iloprost; D066298:In Vitro Techniques; D010974:Platelet Aggregation / Q000187:drug effects; D010982:Platelet-Derived Growth Factor / Q000378:metabolism*; D015230:Prostaglandin D2 / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*
D010982:Platelet-Derived Growth Factor; D011453:Prostaglandins; D011464:Epoprostenol; D000527:Alprostadil; D016285:Iloprost; C043867:cicaprost; D015230:Prostaglandin D2